Areteia Therapeutics is a new biotechnology company committed to putting asthma patients in better control of their disease—and back in control of their ...
Areteia Therapeutics, Inc
Pharmaceutical company in Chapel Hill, North Carolina
Address: 101 Glen Lennox Dr Suite 300, Chapel Hill, NC 27517
People also ask
Who is the CEO of Areteia Therapeutics?
Where is Areteia Therapeutics headquarters?
What is Dexpramipexole used for?
What is eosinophilic asthma?
Feb 13, 2024 · Areteia Therapeutics, Inc. (“Areteia”) today announced $75 million in additional Series A financing to support expansion of the current ...
Areteia Therapeutics is a new biotechnology company committed to putting asthma patients in better control of their disease—and back in control of their lives—with the first potential oral drug for eosinophilic asthma. Website www.areteiatx.com.
Feb 13, 2024 · CHAPEL HILL, N.C., February 13, 2024--Areteia Therapeutics, Inc. ("Areteia") today announced $75 million in additional Series A financing to ...
Areteia Therapeutics - Crunchbase Company Profile & Funding
www.crunchbase.com › organization › ar...
Areteia Therapeutics is a biotechnology company committed to putting asthma patients in better control of their disease.
Areteia Therapeutics is a clinical-stage biopharmaceutical company, focused on developing novel therapeutics for respiratory diseases.
Feb 14, 2024 · A Chapel Hill company thinks its drug has the potential to be the first oral therapy to treat patients with severe, uncontrolled asthma.